Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
This research aims to evaluate community health actions focused on women aged 30 to 65 who are living in vulnerable situations in the outer areas of Reunion Island. The study is designed to assess the effectiveness of these actions in promoting cervical cancer screening by comparing self-screening methods to those performed by health professionals. The trial focuses on human papillomavirus HPV, a risk factor for anal cancer, in people living with HIV. Participants will engage in small group workshops to raise awareness about cervical cancer screening through discussion groups. Additionally, women who are not up to date with their cervical cancer screening will be offered an HPV self-test using a vaginal swab during an individual consultation. This randomized controlled crossover study compares the acceptability and concordance of self-screening versus professional screening. During the study, researchers will monitor how many women complete cervical cancer screening within three months after the community health intervention. Participants will attend awareness sessions and may perform self-testing. The study will track screening completion rates to measure the impact of the interventions. The trial is expected to run until March 2028, with participants followed for at least three months after intervention.
Actively Recruiting
Researchers are studying adult patients with unresectable or metastatic HER2-low and HER2-ultralow expressing breast cancer who have either received prior chemotherapy in the metastatic setting or have hormone receptor-positive disease not suitable for endocrine therapy. The study aims to observe the real-world use and effects of Trastuzumab deruxtecan T-DXd and conventional chemotherapy in these populations. This observational study collects data without administering any study drugs directly, focusing on patient characteristics, treatment patterns, and safety. Participants will be grouped into those receiving T-DXd according to approved medical guidelines and those treated with conventional chemotherapy, including drugs like capecitabine and paclitaxel. The study records treatment details and the management of any adverse reactions, with Group 2 patients contributing baseline data on conventional chemotherapy. Treatments are given as part of routine clinical care, following the Summary of Product Characteristics, without experimental interventions. During the study, participants treatment courses will be tracked for up to approximately 37 months. Researchers will evaluate the time to next treatment, treatment discontinuation, safety events, and patients impressions of treatment tolerability and quality of life. Data collection includes physician reports, patient diaries, and quality of life questionnaires. This long-term monitoring helps to understand treatment patterns and patient experiences in real-world settings.
Actively Recruiting
Large hiatal hernia LHH affects about half of laparoscopic antireflux surgeries and often recurs after repair, with up to 30% recurrence reported within two years. Researchers are studying whether adding a biosynthetic absorbable mesh to the standard suture repair reduces the chance of hernia coming back, without increasing complications. This phase III trial compares mesh reinforcement to no mesh in patients with symptomatic LHH to better understand which approach offers improved outcomes. Participants will undergo laparoscopic hiatal hernia repair either with or without the use of a biosynthetic absorbable mesh patch. This randomized, parallel-group study evaluates two groups one receiving mesh reinforcement and the other receiving standard suture repair alone. The trial lasts at least two years, focusing on the rate of hernia recurrence and other health outcomes following surgery. During the study, participants will have regular assessments including imaging to detect hernia recurrence at 24 months. Quality of life will be measured using questionnaires GIQLI, SF36, EQ-5D-5L, EQ-VAS at multiple time points from the day of surgery through two years. Researchers will also monitor complications, fever, weight, and blood pressure to track safety and overall health. This comprehensive follow-up aims to evaluate both the effectiveness and cost-effectiveness of mesh use in LHH repair.
Actively Recruiting
Researchers are studying the use of herbal medicine among patients with moderate to end-stage chronic kidney disease CKD in Re9union Island. The study aims to understand how common herbal medicine use is in this group and whether it affects the progression of kidney disease over one year. This is important because little is known about the impact of phytotherapy, especially in CKD patients who may be more vulnerable to kidney damage. Participants will be identified by nephrologists and asked to complete questionnaires about their use of herbal medicines. The study focuses on patients with CKD stages 3 to 5 who are not on dialysis and excludes transplant recipients. The research will gather detailed information on herbal medicine use and attempt to link specific herbs to changes in kidney function over time. During the study, participants will complete questionnaires administered by investigators at their care centers. Researchers will measure the proportion of patients using traditional herbal medicine at the start and analyze kidney disease progression over the year. The study involves regular follow-up and assessment to understand the relationship between phytotherapy and kidney health in this population, with a total participation period of about one year.